Hybrid versus catheter ablation for Hypertrophic CardioMyopathy with Atrial Fibrillation (HCM-AF): study protocol for a randomised controlled trial
Introduction Atrial fibrillation (AF) is an independent predictor of adverse outcomes in patients with hypertrophic cardiomyopathy (HCM). Although catheter ablation is highly recommended for general AF populations, it is less effective in maintaining sinus rhythm in patients with HCM associated with...
Saved in:
| Main Authors: | Yan Yao, Zhe Zheng, Lei Song, Min Tang, Le Li, Sipeng Chen, Huiming Guo, Yajie Tang, Yumei Xue |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-10-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/14/10/e089284.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Atrial Fibrillation in Hypertrophic Cardiomyopathy
by: G. A. Ignatenko, et al.
Published: (2021-05-01) -
ATRIAL FIBRILLATION AND FLUTTER IN HYPERTROPHIC CARDIOMYOPATHY
by: N. S. Krylova, et al.
Published: (2015-05-01) -
HCM-Echo-VAR-Ensemble: Deep Ensemble Fusion to Detect Hypertrophic Cardiomyopathy in Echocardiograms
by: Abdulsalam Almadani, et al.
Published: (2025-01-01) -
Mid-Cavitary Obstruction in Hypertrophic Cardiomyopathy (HCM): A Rare Case Report and Management Approach
by: Rajeev Bharadwaj, et al.
Published: (2025-04-01) -
Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA‐HCM
by: Caroline J. Coats, et al.
Published: (2024-08-01)